✦ LIBER ✦

Gemzar (GEM) + Mitimycin C (MMC) in patients with advanced pancreatic cancer (APC)

✍ Scribed by I. Bazin; A. Garin; J. Bulat; M. Narimanov; D. Nosov; D. Titov; A. Popov; R. Nasyrova; S. Tjulandin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twice-weekly gem and concurrent RT in pa

✍ G. Boz; A. De Paoli; R. Innocente; C. Rossi; G. Tosolini; C. Bassi; M. Falconi; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Phase II trial of alimta plus gemzar adm

✍ Kindler, H.; Strickland, D.; Dugan, W.; Visconti, J.; Liebman, J.; Hochster, H.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Phase II trial of mitomycin (MMC) and ge

✍ Reck, M; von Pawel, J; Seipel, G; Seemann, M; Gatzemeier, U 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Isolated hypoxic perfusion with mitomyci

✍ Matthias Lorenz; Henrik Petrowsky; Stefan Heinrich; Gunnar Janshon; Elsbeth Stai 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 535 KB

P-201 First-line chemotherapy with gemza

✍ Kim, Sun Young; Sudershan, Gambhir; Villalon, Antonio H.; Shaharyar, Shaharyar; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

6603 A phase II study of erlotinib in pa

✍ Iyer, R.; Khushalani, N.; Tan, W.; Litwin, A.; LeVea, C.; Hutson, A.; Tucker, C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB